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Abstract
We performed a retrospective cohort study of 3530 women treated for cervical
intraepithelial neoplasia (CIN) in Helsinki University Central Hospital, Finland,
to investigate whether CIN treatment itself affects pregnancy incidence and out-
come. We estimated the incidence of live births, miscarriages, extrauterine preg-
nancies, molar pregnancies, and termination of pregnancies (TOPs) before and
after CIN treatment using nationwide registers. Women were followed up until
death, emigration, sterilization, or the end of 2004. The comparison of inci-
dence of pregnancy outcomes before and after the treatment was estimated by
calculating hazard ratios (HRs) with conditional Poisson regression. After
76,162 woman-years of follow-up, the incidence of any pregnancy remained
constant over CIN-treatment, HR 1.02 and 95% confidence interval (CI)
0.97–1.08, but the incidence of the first pregnancy was significantly elevated
after treatment, HR 1.13, and 95% CI 1.03–1.23. The incidence of live births
was significantly elevated after treatment, HR 1.08 and 95% CI 1.01–1.15. Inci-
dence of miscarriages, TOPs, extrauterine pregnancies, and molar pregnancies
was not elevated. TOPs was significantly increased in the first pregnancy, HR
1.40, 95% CI 1.15–1.72 and after treatment by the loop electrosurgical excision
procedure (LEEP), HR 1.36, 95% CI 1.15–1.60. CIN treatment did not reduce
pregnancy incidence and women had more live births after than before CIN
treatment. TOPs was more common in the first pregnancy or after treatment
by LEEP. We encourage research on the psychosocial consequences of CIN
treatment also in other countries and settings.
Introduction
Evidence linking cervical intraepithelial neoplasia (CIN)
treatments, like cervical conization, to later increase in
preterm deliveries, low birthweight, and perinatal mortal-
ity is extensive [1–3]. Effects of the cervical conization
itself on the incidence of pregnancies, live births, and
other types of pregnancies are less clear. The largest study
so far showed that the incidence of pregnancy or live
birth was actually higher among the CIN-treated women
compared to the age-matched reference population,
and also the risk of induced abortion and extrauterine
pregnancy was higher in CIN patients than the reference
cohort [4].
Women with CIN differ from the general population in
several significant ways: they smoke more, have more sex-
ually transmitted infections, are more often multiparous,
have more sexual partners during their lives, and they are
younger at sexual debut [5]—all these factors are capable
of affecting fertility as well. Therefore, comparing the
treated to healthy might only reflect differences in group-
specific fertility patterns and hence dilute or even mask
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the direction and magnitude of the true effect of the
intervention, CIN treatment, on the studied outcomes.
Our objective was to examine the effects of CIN treat-
ment itself upon incidence of live births and other preg-
nancy outcomes—miscarriages, abortions, extrauterine
pregnancies, and molar pregnancies—by comparing the
CIN patients’ pregnancy outcomes before and after CIN
treatment with those within a cohort of CIN-treated
women. The previous analysis [4] could not adequately
take into account the above factors; there could have been
residual confounding left in the results—they may not
reflect merely the effect of CIN treatment itself on the
outcomes studied, but rather the differences between
women with and without CIN. The current study offers a
more appropriate approach to study the effect of CIN
treatment.
Material and Methods
To study the possible effect of CIN treatment on preg-
nancy outcome, we compared the incidence of different
types of pregnancies before and after CIN treatment
within a cohort of CIN-treated women. The initial study
group comprised 7253 women treated for CIN with cold
knife conization (CKC), cryocoagulation (cryo), laser con-
ization or ablation, or with a loop electrosurgical excision
procedure (LEEP), between 1974 and 2001 at Helsinki
University Central Hospital, Finland, a reference center
for colposcopy in the district.
In our data, median age at treatment was lower than at
the first pregnancy, so women were more likely to be
pregnant after than before the CIN treatment. Presenting
results of a cohort where treated women serve as their
own controls, adjusting only for age at treatment and age
at endpoint does not sufficiently control for age, therefore
we fitted all models for a matched reference cohort as
well. For each woman treated, five individually age- and
municipality-matched controls were selected from the
Finnish Population Register, resulting in 36,265 women
in the initial reference cohort.
Data covering all pregnancy outcomes were available
only from the beginning of 1974. Hence, from the initial
study population we included in the study only women
turning 16 at the onset of nationwide registers or youn-
ger, 1974, that is, women born 1958 or later. After this
exclusion, the final study population included 3530
women treated for CIN and the reference cohort was
reduced to 17,451 women.
Birth dates of their live-born children (date of live sin-
gleton birth) and possible dates of emigration or death
were retrieved from the population registry. Precise dates
of all other pregnancy outcomes (miscarriage, extrauterine
pregnancy, molar pregnancy, and termination of preg-
nancy [TOP]) and the date of possible sterilization were
gathered from the THL’s (National Institute for Health
and Welfare) Care Registers for Social Welfare and
Health, who have been shown to have high completeness
and validity [6].
A live birth here means delivery of a live-born baby with
over 24 weeks of gestation; miscarriages occurred before
24 gestational weeks; extrauterine pregnancy is pregnancy
outside the uterus; molar pregnancy means benign gesta-
tional trophoblastic neoplasia; and TOP means a medically
performed abortion, either by medication or by dilatation
and curettage. Pregnancy incidence denotes incidence of
all endpoints: live births, TOPs, extrauterine pregnancies,
miscarriages, and molar pregnancies.
The incidence of the outcomes studied was calculated
over consecutive follow-up periods for each woman in
both cohorts to account for the changing values of
explanatory variables over the whole follow-up time. We
calculated the conception time of each pregnancy by
median estimates of the duration of pregnancy for each
outcome and were thus able to determine whether a preg-
nancy had started before or after the CIN treatment. (1)
A live birth: 280 days before the actual birth. (2) Miscar-
riage or TOP: 63 days before. (3) Extrauterine pregnancy:
56 days. (4) Molar pregnancy: 77 days. All women were
followed up until sterilization, turning 50, emigration,
death, or at the end of 2004. The median age at treatment
was 26 and age at first pregnancy among the 2637 treated
women who became pregnant at least once was 24.
Statistical analysis
We performed an internal analysis within the cohort of
CIN-treated women and the reference cohort indepen-
dently. Hazard ratios (HRs) were calculated by comparing
the adjusted incidence of each endpoint after versus
before the treatment of CIN using conditional Poisson
regression [7]. The adjusted model-based HR—the final
results presented in Tables 2 and 3—then took the form
of the ratio between the model-based HRs for the treated
and the model-based hazard rate for the reference group.
In this way, the final results for the treated women could
be adjusted for the general pattern of fertility in the gen-
eral population represented in our study by the reference
cohort. Comparisons between risks were reported as HRs
with 95% confidence intervals (CIs). Statistical signifi-
cance of the analyzed variables was obtained by compar-
ing appropriate hierarchical models. The CIs were
calculated by the delta method [8].
All models were adjusted for the number of pregnan-
cies (0, 1, 2, 3+) and children (0, 1, 2, 3+), age at treat-
ment and age at the beginning of each pregnancy,
municipality, grade of CIN, treatment method, calendar
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year, and whether the type of pregnancy in question had
already occurred before the treatment.
In addition to the overall incidence of each pregnancy
outcome, separate similar models were fitted specific to
the number of pregnancies or live births before the index
pregnancy (no pregnancies before, pregnancy or pregnan-
cies but no live births before, one child before, two
children before, or three or more children before the
index pregnancy), specific to the grade of CIN (CIN 1–3),
and to the current method of treatment, LEEP. All statis-
tical analyses were performed with STATA software
(StataCorp 2011, Stata Statistical Software: release 12.1,
College Station, TX).
The research protocol of this study has been approved
by the Ethics Committee Section for Obstetrics and
Gynaecology in the Helsinki-Uusimaa Hospital District
(Admission date: 15 August 2003, 150/E8/03).
Results
Among the 3530 CIN-treated women with 76,162
woman-years of follow-up, we observed altogether 6535
pregnancies of which 4615 were live births, 1545 TOPs,
208 miscarriages, 97 extrauterine pregnancies, and 70
molar pregnancies (Table 1).
The incidence of any pregnancy was similar after and
before the CIN treatment, HR 1.02 and 95% CI
0.97–1.08, but the incidence of the first-ever pregnancy
was significantly elevated after treatment, HR 1.13 and
95% CI 1.03–1.23 (Table 2). The incidence of live births
was significantly higher after overall treatment, HR 1.08
and 95% CI 1.01–1.15, in the first-ever pregnancy, HR
1.16 and 95% CI 1.04–1.28, and in pregnancies after one
or two children (Table 2). Overall incidences of TOPs,
miscarriages, molar pregnancies, and extrauterine preg-
nancies were not statistically significantly increased after
CIN treatment (Table 2). Overall incidence of TOPs was
slightly but not significantly elevated, HR 1.07 and 95%
CI 0.95–1.20, and reached statistical significance when the
first-ever pregnancy was TOP, HR 1.40 and 95% CI
1.15–1.72 (Table 2). Incidence of extrauterine pregnancies
was constantly elevated after treatment, regardless of
pregnancy history, but the difference was statistically
significant only in pregnancies that began after one child
HR 3.50 and 95% CI 1.36–9.03 (Table 2).
We did not observe significant differences between the
grades of CIN in any of the outcomes studied (Table 3).
Results of those women treated with LEEP did not signifi-
cantly differ from those of the whole study population,
although the incidence of TOPs was statistically signifi-
cantly and higher after than before the treatment, HR
1.36 and 95% CI 1.15–1.60 (Table 3).
Discussion
Among over 3500 CIN-treated women with 76,000
woman-years of follow-up, we observed a significant
increase in the incidence of live births after CIN treatment.
Table 1. Numbers of women, woman-years, and endpoints.
N Woman-years Pregnancies Live births
Termination of
pregnancy Miscarriages
Extrauterine
pregnancies
Molar
pregnancies
Overall treated 3530 76,162 6535 4615 1545 208 97 70
Before 42,032 2827 1730 927 94 45 31
After 34,130 3708 2885 618 114 52 39
Overall reference 17,451 376,594 28,499 21,926 5193 851 266 263
Before 205,810 12,504 8560 3307 379 146 112
After 170,784 15,995 13,366 1886 472 120 151
CIN 1 total 1,180 24,141 2002 1419 465 80 22 16
Before 13,406 809 482 269 39 12 7
After 10,735 1193 937 196 41 10 9
CIN 2 total 1720 38,335 3367 2367 797 104 58 41
Before 19,425 1301 771 456 39 19 16
After 18,910 2066 1596 341 65 39 25
CIN 3 total 630 13,686 1166 829 283 24 17 13
Before 9201 717 477 202 16 14 8
After 4485 449 352 81 8 3 5
LEEP total 2317 46,220 3588 2569 851 92 38 38
Before 32,427 2168 1422 613 71 35 27
After 13,793 1420 1147 238 21 3 11
Overall for treated and reference cohort separately. For the treated only according to the grade of CIN, and for those treated with LEEP. All num-
bers total, before, and after the treatment in all categories. CIN, cervical intraepithelial neoplasia; LEEP, loop electrosurgical excision procedure.
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Pregnancy incidence remained stable through the CIN
treatment, but significantly more women became pregnant
at least once after treatment.
In the current study, all comparisons before and after
pregnancy were made within the cohort of treated women
and reference cohort and all models are adjusted for all
possible confounding factors retrievable from the registers
used (parity, age, method of treatment, grade of CIN,
place of residence, previous incidence of the outcome
studied, and time of treatment). This setting allows for
drawing broader conclusions about the direct effect of
CIN treatment itself on later fertility than in a setting
where the comparisons are made between the treated and
a healthy reference group [4].
The number of miscarriages and extrauterine pregnan-
cies in the data is small, and many results concerning these
endpoints lack statistical power. This is most likely due to
the fact that mainly those women who were taken as in-
patients appeared in nationwide registers during the study
period. This remained the same throughout the study per-
iod and hence does not systematically bias the results. As
women treated for CIN were collected from the hospital
register, some women might have been treated for CIN
before the first treatment in our data or might have been
treated again later. This phenomenon would rather dilute
than exaggerate the results observed in this setting and as
these events have been rare, these cannot therefore be con-
sidered to seriously bias the conclusions.
Pregnancy incidence and especially live birth incidence
increased after CIN treatment. All results were adjusted
for age-specific fertility patterns of general population, so
a natural increase in reproductive activity with advancing
age (median age at treatment was 26) does not explain
this observation. Most likely the surgical procedure itself
does not directly promote reproduction either. We know
that CIN treatment causes anxiety and distress [5, 9].
Even though the psychosocial consequences of CIN treat-
ment was not studied here, we cannot rule out that a
psychosocial effect of CIN treatment might increase rather
than decrease the will to acquire children.
Table 2. Pregnancy outcome.
Pregnancies Live births
Termination of
pregnancy* Miscarriages*
Extrauterine
pregnancies*
Molar
pregnancies*
Overall 1.02 (0.97–1.08) 1.08 (1.01–1.15) 1.07 (0.95–1.20) 0.93 (0.68–1.27) 1.19 (0.73–1.95) 0.93 (0.54–1.62)
First ever pregnancy 1.13 (1.03–1.23) 1.16 (1.04–1.28) 1.40 (1.15–1.72) 1.21 (0.72–2.04) 1.37 (0.61–3.08) 0.99 (0.39–2.51)
No live births before 0.95 (0.82–1.10) 0.93 (0.84–1.04) 1.06 (0.77–1.45) 0.94 (0.41–2.19) 1.28 (0.43–3.80) 0.52 (0.12–2.14)
1 live birth 1.14 (1.03–1.26) 1.20 (1.07–1.35) 1.09 (0.84–1.43) 0.95 (0.56–1.61) 3.50 (1.36–9.03) 0.96 (0.39–2.36)
2 live births 1.12 (0.93–1.34) 1.45 (1.15–1.82) 0.82 (0.59–1.14) 0.83 (0.32–2.16) 0.46 (0.12–1.81) 1.73 (0.30–10.0)
3+ live births 0.77 (0.55–1.10) 0.87 (0.56–1.35) 0.59 (0.32–1.23) 0.11 (0.01–0.75) NA NA
Hazard ratios of all endpoints, after versus before treatment of CIN. All results are based on conditional Poisson regression models [6] by compar-
ing the incidence of outcome in question before versus after the CIN treatment. All models are adjusted for the method of CIN treatment, grade
of histology, age at treatment, age at endpoint, place of residence, calendar year, and age- and municipality-matched reference population. The
overall results are furthermore adjusted for pregnancy history. Other results are retrieved from stratified models according to pregnancy history:
women with no pregnancies before the index pregnancy (the first-ever pregnancy); women with pregnancy or pregnancies but no live births
before the index pregnancy (no live births before); and women with 1, 2, or 3 or more live births before the index pregnancy. NA, not available
due to toofew observations; CIN, cervical intraepithelial neoplasia; LEEP, loop electrosurgical excision procedure.
*Adjusted also for whether the endpoint in question had already occurred at least once.
Table 3. Overall pregnancy outcomes according to grade of CIN and for LEEP separately.
Pregnancies Live births
Termination of
pregnancy* Miscarriages*
Extrauterine
pregnancies*
Molar
pregnancies*
CIN 1 1.11 (1.02–1.22) 1.20 (1.07–1.35) 1.21 (1.00–1.47) 0.92 (0.58–1.45) 1.11 (0.46–2.67) 1.04 (0.38–2.89)
CIN 2 0.99 (0.92–1.06) 1.05 (0.96–1.15) 1.04 (0.90–1.21) 0.95 (0.62–1.45) 1.54 (0.84–2.82) 0.76 (0.39–1.50)
CIN 3 0.97 (0.86–1.10) 0.96 (0.83–1.10) 1.30 (1.00–1.69) 0.95 (0.40–2.24) 0.84 (0.23–3.03) 1.40 (0.44–4.44)
LEEP 1.10 (1.03–1.22) 1.12 (1.03–1.22) 1.36 (1.15–1.60) 0.74 (0.44–1.24) 0.73 (0.21–2.50) 2.52 (0.93–4.41)
All results based on conditional Poisson regression models [6] by comparing the incidence of outcome in question before versus after CIN treat-
ment. Results for CIN grades 1–3 are adjusted for pregnancy history, for the method of CIN treatment, age at treatment, age at endpoint, place
of residence, calendar year, and age- and municipality-matched reference population. Results for LEEP are adjusted for pregnancy history, the
grade of histology, age at treatment, age at endpoint, place of residence, calendar year, and age- and municipality-matched reference population;
CIN, cervical intraepithelial neoplasia.
*Adjusted also for whether the endpoint in question had already occurred at least once.
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In our previous study, the incidence of different preg-
nancy types was compared between CIN-treated women
and the healthy reference cohort. Incidences of TOPs and
extrauterine pregnancy were significantly elevated among
the treated women [4]. In the current study, overall TOP
incidence was not increased. However, among women
treated with LEEP (66% of the study population) and in
the first-ever pregnancy, TOPs were significantly more
common after treatment. As LEEP is the dominating
treatment method in the most recent periods (used in the
current hospital settings since 1991), these two findings
could correlate to each other. The CIN treatment may
hence cause a small but significant increase in TOP inci-
dence. As the majority, over 95%, of TOPs in Finland, is
made due to social reasons [6], the psychological effects
of CIN treatment might play a small role in the observed
increase in TOPs incidence after treatment. However,
supporting direct evidence was beyond the scope of our
study setting.
Incidence of extrauterine pregnancies was slightly
increased after treatment, but due to the small number of
events in the data all but one result lacked statistical sig-
nificance, and strong conclusions cannot therefore in our
opinion be made.
The overall incidence of miscarriages was not increased,
and a slight but not statistically significant increase was
observed only among women with no previous preg-
nancy. If the CIN treatment was subject to miscarriages,
the incidence should be elevated regardless of pregnancy
history.
Cervical conization effectively prevents cervical cancer
[10]. A significant number of these procedures are made
for women during their fertile years. Even though vast
evidence links conization to preterm delivery, our findings
are reassuring for physicians: the pregnancy incidence
after CIN treatment did not decrease and adjusted
livebirth incidence was higher after than before CIN treat-
ment. As the results are based on a large data set with a
nationwide follow-up of women treated in a public
hospital, we consider our findings’ generalisability as
satisfactory for our country. We did observe a significant
increase in TOP incidence after LEEP and in the first
pregnancy as well, and increased reproductive activity
after the treatment. In light of the findings of the current
study, more research about the psychosocial consequences
of CIN treatment is strongly encouraged in addition to
countries and settings.
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